StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) income statement

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3083% above fair value
$267.14−5.56 (-2.04%)

Close on Nov 19, 2026Market cap $643.09BP/E 40.5Yield 1.92%

Johnson & Johnson income statement

Ratios

Latest available, balances at Sep 27, 2026

Profitability, TTM

Gross margin
67.6%
Operating margin
–
Net margin
16.2%
Return on equity, FY2025
35.0%

Financial strength

Current ratio
1.02
Debt to equity
0.55
Debt to assets
22.6%
Cash to current liabilities
30.5%

Valuation

P/E ratio
40.5
Price to sales
6.47
Price to book
7.89
Dividend yield
1.92%

See a number that looks wrong?